ArticleJournal of thoracic disease2026
Basilar segmentectomy for early-stage non-small cell lung cancer: is it worth preserving the S6 segment?
Article in Journal of thoracic disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Even though segmentectomy has become a new standard for early-stage non-small cell lung cancer (NSCLC), the benefits of basilar segmentectomy (BS) remain unclear. This study aims to characterize postoperative lung volume changes following BS compared to lower lobectomy (LL) using three-dimensional computed tomography (3D-CT) analysis. Methods: This is a single-center retrospective study including patients who underwent surgery of the lower lobe for early-stage NSCLC between November 2015 and November 2021. Surgery could either be LL or BS. 3D-CT reconstruction was used to assess lung volumes before and after surgery. Primary outcome was ipsilateral lung volume variation after BS and LL and secondary outcome was total, contralateral and segment volume lung variation. Results: Forty patients were included (28 LL and 12 BS). No significant difference was found for ipsilateral lung volume variation between BS and LL (-28.1% Conclusions: While BS does not significantly increase overall lung volume preservation compared to LL, it offers a distinct and localized compensatory remodeling of the preserved S6 segment. This specific pattern of lung adaptation helps preserve functional lung tissue, potentially facilitating future surgical interventions for metachronous tumors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.